| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.01 |